Hemodialysis Catheters Market by Product (Cuffed Tunneled Catheter, Non-cuffed Tunneled Catheter, and Non-tunneled Catheter), Tip Configuration (Step-tip Catheters, Split-tip Catheters, and Symmetric Catheters), Material (Silicone and Polyurethane), and E

Hemodialysis Catheters Market by Product (Cuffed Tunneled Catheter, Non-cuffed Tunneled Catheter, and Non-tunneled Catheter), Tip Configuration (Step-tip Catheters, Split-tip Catheters, and Symmetric Catheters), Material (Silicone and Polyurethane), and End User (Hospitals, Home Dialysis, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

The global hemodialysis catheters market was valued at $736 million in 2020 and expected to reach $1163 million in 2030, at a CAGR 4.66% from 2021 to 2030.

The process of blood filtration of an individual with kidney failure is called hemodialysis. Hemodialysis is a procedure that assists with filtering wastes and water from blood, for a patients suffering from kidney failure. Consequently, hemodialysis assists with controlling pulse and equilibrium of sodium, potassium, and calcium in the body, as a functional kidney would do . It is done by associating a dialysis machine to the patient involving a catheter as a connecting point. The catheter incorporates two sorts of lumens (adaptable tubular passage) for transmission of blood, which are hued in red and blue for clear identification during dialysis process. The red colored lumen (atrial lumen) draws blood from the patient and transmits it to the dialysis machine for filtration, while the blue hued lumen (venous lumen) returns the blood to the patient after filtration from dialysis machine.

The catheter is embedded in one of the huge veins, namely, superior vena cava or by penetrating the inner jugular vein in the neck to push it inside the chest.

The development of the hemodialysis catheters market is driven by variables, for example, increase in prevalence of end-stage renal diseases (ESRD) and increase in number of patients experiencing chronic kidney problems. Moreover, low accessibility of kidney donors for transplantation and innovative improvement in dialysis equipment fuel the market growth. However, surge in the price of dialysis procedures is considered as a major restraint for this market.

Moreover, rise in lifestyle disorders such as diabetes and hypertension are taking over the population and affecting the renal health of people.

The World Health Organization (WHO) on January 30, 2020 declared a global pandemic namely COVID-19. Coronavirus has impacted around 210 countries across the globe. As a precautionary measure the state run administration all over the globe declared a lockdown and social distancing practice. States have also given requirements and avoidances on undertakings and elective medical procedures. With surge in lockdown, there is rise in hypertension and diabetes, which, in turn, have affected the patients suffering from acute kidney injury (AKI) and chronic kidney disease (CKD). Therefore, they are relied on the dialysis industry for treatment but with expensive procedures they have also tend to restrain from the treatments. Thus COVID-19 had a neutral impact on the industry.

The hemodialysis catheters market is segmented on the basis of product, tip configuration, material, end user, and region. According to the product, the market is segregated into cuffed tunneled catheters, non-cuffed tunneled catheters and non-tunneled catheters. Depending on material, the market is categorized into silicone and polyurethane. As per tip configuration, it is classified into step-tip catheters, split-tip catheters, and symmetric catheters. By end user, it is fragmented into hospitals, clinics/dialysis centers, and home dialysis. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Major key players operating in hemodialysis catheters include Becton, Dickinson and Company, Omnicell Inc., Scriptpro Llc, Parata, Lonza, Baxter, Danaher, Capsa Healthcare, Cerner Corporation, RX Safe.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of four regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS


By Product

Cuffed Tunneled Catheter
Non-cuffed Tunneled Catheters
Non-tunneled Catheters

By Tip Configuration

Step-tip Catheters
Split-tip Catheters
Symmetric Catheter

By Material

Silicone
Polyurethane

By End User

Hospitals
Home Dialysis
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA


CHAPTER 1: INTRODUCTION
1.1.Report Description
1.2.Key Market Segments
1.3.Key Benefits
1.4.Research Methodology
1.4.1.Primary Research
1.4.2.Secondary Research
1.4.3.Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1.Market Definition and Scope
3.2.Key Findings
3.2.1.Top Investment Pockets
3.2.2.Top Winning Strategies
3.3.Porter's Five Forces Analysis
3.3.1.Bargaining Power of Suppliers
3.3.2.Threat of New Entrants
3.3.3.Threat of Substitutes
3.3.4.Competitive Rivalry
3.3.5.Bargaining Power among Buyers
3.4.Market Share Analysis/Top Player Positioning
3.4.1.Market Share Analysis/Top Player Positioning 2020
3.5.Market Dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6. COVID-19 Impact Analysis
CHAPTER 4: HEMODIALYSIS CATHETERS MARKET, BY PRODUCT
4.1.Market Overview
4.1.1Market Size and Forecast, By Product
4.2.Cuffed Tunneled Catheter
4.2.1.Key Market Trends, Growth Factors and Opportunities
4.2.2.Market Size and Forecast, By Region
4.2.3.Market Share Analysis, By Country
4.3.Non Cuffed Tunneled Catheter
4.3.1.Key Market Trends, Growth Factors and Opportunities
4.3.2.Market Size and Forecast, By Region
4.3.3.Market Share Analysis, By Country
4.4.Non Tunneled Catheter
4.4.1.Key Market Trends, Growth Factors and Opportunities
4.4.2.Market Size and Forecast, By Region
4.4.3.Market Share Analysis, By Country
CHAPTER 5: HEMODIALYSIS CATHETERS MARKET, BY TIP CONFIGURATION
5.1.Market Overview
5.1.1Market Size and Forecast, By Tip Configuration
5.2.Step Tip Catheter
5.2.1.Key Market Trends, Growth Factors and Opportunities
5.2.2.Market Size and Forecast, By Region
5.2.3.Market Share Analysis, By Country
5.3.Split Tip Catheter
5.3.1.Key Market Trends, Growth Factors and Opportunities
5.3.2.Market Size and Forecast, By Region
5.3.3.Market Share Analysis, By Country
5.4.Symmetric Catheter
5.4.1.Key Market Trends, Growth Factors and Opportunities
5.4.2.Market Size and Forecast, By Region
5.4.3.Market Share Analysis, By Country
CHAPTER 6: HEMODIALYSIS CATHETERS MARKET, BY MATERIAL
6.1.Market Overview
6.1.1Market Size and Forecast, By Material
6.2.Silicone
6.2.1.Key Market Trends, Growth Factors and Opportunities
6.2.2.Market Size and Forecast, By Region
6.2.3.Market Share Analysis, By Country
6.3.Polyurethane
6.3.1.Key Market Trends, Growth Factors and Opportunities
6.3.2.Market Size and Forecast, By Region
6.3.3.Market Share Analysis, By Country
CHAPTER 7: HEMODIALYSIS CATHETERS MARKET, BY END USER
7.1.Market Overview
7.1.1Market Size and Forecast, By End User
7.2.Hospitals
7.2.1.Key Market Trends, Growth Factors and Opportunities
7.2.2.Market Size and Forecast, By Region
7.2.3.Market Share Analysis, By Country
7.3.Home Dialysis
7.3.1.Key Market Trends, Growth Factors and Opportunities
7.3.2.Market Size and Forecast, By Region
7.3.3.Market Share Analysis, By Country
7.4.Others
7.4.1.Key Market Trends, Growth Factors and Opportunities
7.4.2.Market Size and Forecast, By Region
7.4.3.Market Share Analysis, By Country
CHAPTER 8: HEMODIALYSIS CATHETERS MARKET, BY REGION
8.1.Market Overview
8.1.1Market Size and Forecast, By Region
8.2.North America
8.2.1.Key Market Trends and Opportunities
8.2.2.Market Size and Forecast, By Product
8.2.3.Market Size and Forecast, By Tip Configuration
8.2.4.Market Size and Forecast, By Material
8.2.5.Market Size and Forecast, By End User
8.2.6.Market Size and Forecast, By Country
8.2.7.United States Hemodialysis Catheters Market
8.2.7.1.Market Size and Forecast, By Product
8.2.7.2.Market Size and Forecast, By Tip Configuration
8.2.7.3.Market Size and Forecast, By Material
8.2.7.4.Market Size and Forecast, By End User
8.2.8.Canada Hemodialysis Catheters Market
8.2.8.1.Market Size and Forecast, By Product
8.2.8.2.Market Size and Forecast, By Tip Configuration
8.2.8.3.Market Size and Forecast, By Material
8.2.8.4.Market Size and Forecast, By End User
8.2.9.Mexico Hemodialysis Catheters Market
8.2.9.1.Market Size and Forecast, By Product
8.2.9.2.Market Size and Forecast, By Tip Configuration
8.2.9.3.Market Size and Forecast, By Material
8.2.9.4.Market Size and Forecast, By End User
8.3.Europe
8.3.1.Key Market Trends and Opportunities
8.3.2.Market Size and Forecast, By Product
8.3.3.Market Size and Forecast, By Tip Configuration
8.3.4.Market Size and Forecast, By Material
8.3.5.Market Size and Forecast, By End User
8.3.6.Market Size and Forecast, By Country
8.3.7.France Hemodialysis Catheters Market
8.3.7.1.Market Size and Forecast, By Product
8.3.7.2.Market Size and Forecast, By Tip Configuration
8.3.7.3.Market Size and Forecast, By Material
8.3.7.4.Market Size and Forecast, By End User
8.3.8.Germany Hemodialysis Catheters Market
8.3.8.1.Market Size and Forecast, By Product
8.3.8.2.Market Size and Forecast, By Tip Configuration
8.3.8.3.Market Size and Forecast, By Material
8.3.8.4.Market Size and Forecast, By End User
8.3.9.U.K Hemodialysis Catheters Market
8.3.9.1.Market Size and Forecast, By Product
8.3.9.2.Market Size and Forecast, By Tip Configuration
8.3.9.3.Market Size and Forecast, By Material
8.3.9.4.Market Size and Forecast, By End User
8.3.10.Italy Hemodialysis Catheters Market
8.3.10.1.Market Size and Forecast, By Product
8.3.10.2.Market Size and Forecast, By Tip Configuration
8.3.10.3.Market Size and Forecast, By Material
8.3.10.4.Market Size and Forecast, By End User
8.3.11.Spain Hemodialysis Catheters Market
8.3.11.1.Market Size and Forecast, By Product
8.3.11.2.Market Size and Forecast, By Tip Configuration
8.3.11.3.Market Size and Forecast, By Material
8.3.11.4.Market Size and Forecast, By End User
8.3.12.Rest Of Europe Hemodialysis Catheters Market
8.3.12.1.Market Size and Forecast, By Product
8.3.12.2.Market Size and Forecast, By Tip Configuration
8.3.12.3.Market Size and Forecast, By Material
8.3.12.4.Market Size and Forecast, By End User
8.4.Asia-Pacific
8.4.1.Key Market Trends and Opportunities
8.4.2.Market Size and Forecast, By Product
8.4.3.Market Size and Forecast, By Tip Configuration
8.4.4.Market Size and Forecast, By Material
8.4.5.Market Size and Forecast, By End User
8.4.6.Market Size and Forecast, By Country
8.4.7.Japan Hemodialysis Catheters Market
8.4.7.1.Market Size and Forecast, By Product
8.4.7.2.Market Size and Forecast, By Tip Configuration
8.4.7.3.Market Size and Forecast, By Material
8.4.7.4.Market Size and Forecast, By End User
8.4.8.China Hemodialysis Catheters Market
8.4.8.1.Market Size and Forecast, By Product
8.4.8.2.Market Size and Forecast, By Tip Configuration
8.4.8.3.Market Size and Forecast, By Material
8.4.8.4.Market Size and Forecast, By End User
8.4.9.Australia Hemodialysis Catheters Market
8.4.9.1.Market Size and Forecast, By Product
8.4.9.2.Market Size and Forecast, By Tip Configuration
8.4.9.3.Market Size and Forecast, By Material
8.4.9.4.Market Size and Forecast, By End User
8.4.10.India Hemodialysis Catheters Market
8.4.10.1.Market Size and Forecast, By Product
8.4.10.2.Market Size and Forecast, By Tip Configuration
8.4.10.3.Market Size and Forecast, By Material
8.4.10.4.Market Size and Forecast, By End User
8.4.11.South Korea Hemodialysis Catheters Market
8.4.11.1.Market Size and Forecast, By Product
8.4.11.2.Market Size and Forecast, By Tip Configuration
8.4.11.3.Market Size and Forecast, By Material
8.4.11.4.Market Size and Forecast, By End User
8.4.12.Rest Of Asia-pacific Hemodialysis Catheters Market
8.4.12.1.Market Size and Forecast, By Product
8.4.12.2.Market Size and Forecast, By Tip Configuration
8.4.12.3.Market Size and Forecast, By Material
8.4.12.4.Market Size and Forecast, By End User
8.5.LAMEA
8.5.1.Key Market Trends and Opportunities
8.5.2.Market Size and Forecast, By Product
8.5.3.Market Size and Forecast, By Tip Configuration
8.5.4.Market Size and Forecast, By Material
8.5.5.Market Size and Forecast, By End User
8.5.6.Market Size and Forecast, By Country
8.5.7.Brazil Hemodialysis Catheters Market
8.5.7.1.Market Size and Forecast, By Product
8.5.7.2.Market Size and Forecast, By Tip Configuration
8.5.7.3.Market Size and Forecast, By Material
8.5.7.4.Market Size and Forecast, By End User
8.5.8.Saudi Arabia Hemodialysis Catheters Market
8.5.8.1.Market Size and Forecast, By Product
8.5.8.2.Market Size and Forecast, By Tip Configuration
8.5.8.3.Market Size and Forecast, By Material
8.5.8.4.Market Size and Forecast, By End User
8.5.9.South Africa Hemodialysis Catheters Market
8.5.9.1.Market Size and Forecast, By Product
8.5.9.2.Market Size and Forecast, By Tip Configuration
8.5.9.3.Market Size and Forecast, By Material
8.5.9.4.Market Size and Forecast, By End User
8.5.10.Rest of LAMEA Hemodialysis Catheters Market
8.5.10.1.Market Size and Forecast, By Product
8.5.10.2.Market Size and Forecast, By Tip Configuration
8.5.10.3.Market Size and Forecast, By Material
8.5.10.4.Market Size and Forecast, By End User
CHAPTER 9: COMPANY PROFILES
9.1.Becton, Dickinson And Company
9.1.1.Company Overview
9.1.2.Key Executives
9.1.3.Company snapshot
9.1.4.Operating business segments
9.1.5.Product portfolio
9.1.6.Business Performance
9.1.7.Key Strategic Moves and Developments
9.2.Baxter International Inc.
9.2.1.Company Overview
9.2.2.Key Executives
9.2.3.Company snapshot
9.2.4.Operating business segments
9.2.5.Product portfolio
9.2.6.Business Performance
9.2.7.Key Strategic Moves and Developments
9.3.AngioDynamics Inc.
9.3.1.Company Overview
9.3.2.Key Executives
9.3.3.Company snapshot
9.3.4.Operating business segments
9.3.5.Product portfolio
9.3.6.Business Performance
9.3.7.Key Strategic Moves and Developments
9.4.B.braun Melsungen Ag
9.4.1.Company Overview
9.4.2.Key Executives
9.4.3.Company snapshot
9.4.4.Operating business segments
9.4.5.Product portfolio
9.4.6.Business Performance
9.4.7.Key Strategic Moves and Developments
9.5.Cook Group
9.5.1.Company Overview
9.5.2.Key Executives
9.5.3.Company snapshot
9.5.4.Operating business segments
9.5.5.Product portfolio
9.5.6.Business Performance
9.5.7.Key Strategic Moves and Developments
9.6.Fresenius
9.6.1.Company Overview
9.6.2.Key Executives
9.6.3.Company snapshot
9.6.4.Operating business segments
9.6.5.Product portfolio
9.6.6.Business Performance
9.6.7.Key Strategic Moves and Developments
9.7.Medtronic, Inc.
9.7.1.Company Overview
9.7.2.Key Executives
9.7.3.Company snapshot
9.7.4.Operating business segments
9.7.5.Product portfolio
9.7.6.Business Performance
9.7.7.Key Strategic Moves and Developments
9.8.Nikkiso
9.8.1.Company Overview
9.8.2.Key Executives
9.8.3.Company snapshot
9.8.4.Operating business segments
9.8.5.Product portfolio
9.8.6.Business Performance
9.8.7.Key Strategic Moves and Developments
9.9.Nipro Corporation
9.9.1.Company Overview
9.9.2.Key Executives
9.9.3.Company snapshot
9.9.4.Operating business segments
9.9.5.Product portfolio
9.9.6.Business Performance
9.9.7.Key Strategic Moves and Developments
9.10.Toray Medical
9.10.1.Company Overview
9.10.2.Key Executives
9.10.3.Company snapshot
9.10.4.Operating business segments
9.10.5.Product portfolio
9.10.6.Business Performance
9.10.7.Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1.GLOBAL HEMODIALYSIS CATHETERS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 2.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR CUFFED TUNNELED CATHETER, BY REGION, 2020-2030 ($MILLION)
TABLE 3.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR NON CUFFED TUNNELED CATHETER, BY REGION, 2020-2030 ($MILLION)
TABLE 4.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR NON TUNNELED CATHETER, BY REGION, 2020-2030 ($MILLION)
TABLE 5.GLOBAL HEMODIALYSIS CATHETERS MARKET, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 6.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR STEP TIP CATHETER, BY REGION, 2020-2030 ($MILLION)
TABLE 7.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR SPLIT TIP CATHETER, BY REGION, 2020-2030 ($MILLION)
TABLE 8.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR SYMMETRIC CATHETER, BY REGION, 2020-2030 ($MILLION)
TABLE 9.GLOBAL HEMODIALYSIS CATHETERS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 10.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR SILICONE, BY REGION, 2020-2030 ($MILLION)
TABLE 11.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR POLYURETHANE, BY REGION, 2020-2030 ($MILLION)
TABLE 12.GLOBAL HEMODIALYSIS CATHETERS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 13.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR HOSPITALS, BY REGION, 2020-2030 ($MILLION)
TABLE 14.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR HOME DIALYSIS, BY REGION, 2020-2030 ($MILLION)
TABLE 15.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 16.GLOBAL HEMODIALYSIS CATHETERS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 17.NORTH AMERICA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 18.NORTH AMERICA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 19.NORTH AMERICA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 20.NORTH AMERICA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 21.UNITED STATES HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 22.UNITED STATES HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 23.UNITED STATES HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 24.UNITED STATES HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 25.CANADA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 26.CANADA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 27.CANADA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 28.CANADA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 29.MEXICO HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 30.MEXICO HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 31.MEXICO HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 32.MEXICO HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 33.EUROPE HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 34.EUROPE HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 35.EUROPE HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 36.EUROPE HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 37.FRANCE HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 38.FRANCE HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 39.FRANCE HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 40.FRANCE HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 41.GERMANY HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 42.GERMANY HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 43.GERMANY HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 44.GERMANY HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 45.UNITED KINGDOM HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 46.UNITED KINGDOM HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 47.UNITED KINGDOM HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 48.UNITED KINGDOM HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 49.ITALY HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 50.ITALY HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 51.ITALY HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 52.ITALY HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 53.SPAIN HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 54.SPAIN HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 55.SPAIN HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 56.SPAIN HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 57.REST OF EUROPE HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 58.REST OF EUROPE HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 59.REST OF EUROPE HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 60.REST OF EUROPE HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 61.ASIA-PACIFIC HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 62.ASIA-PACIFIC HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 63.ASIA-PACIFIC HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 64.ASIA-PACIFIC HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 65.JAPAN HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 66.JAPAN HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 67.JAPAN HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 68.JAPAN HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 69.CHINA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 70.CHINA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 71.CHINA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 72.CHINA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 73.AUSTRALIA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 74.AUSTRALIA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 75.AUSTRALIA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 76.AUSTRALIA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 77.INDIA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 78.INDIA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 79.INDIA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 80.INDIA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 81.SOUTH KOREA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 82.SOUTH KOREA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 83.SOUTH KOREA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 84.SOUTH KOREA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 85.REST OF ASIA-PACIFIC HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 86.REST OF ASIA-PACIFIC HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 87.REST OF ASIA-PACIFIC HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 88.REST OF ASIA-PACIFIC HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 89.LAMEA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 90.LAMEA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 91.LAMEA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 92.LAMEA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 93.BRAZIL HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 94.BRAZIL HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 95.BRAZIL HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 96.BRAZIL HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 97.SAUDI ARABIA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 98.SAUDI ARABIA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 99.SAUDI ARABIA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 100.SAUDI ARABIA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 101.SOUTH AFRICA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 102.SOUTH AFRICA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 103.SOUTH AFRICA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 104.SOUTH AFRICA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 105.REST OF LAMEA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 106.REST OF LAMEA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
TABLE 107.REST OF LAMEA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 108.REST OF LAMEA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
TABLE 109.BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
TABLE 110.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 111.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 112.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 113.BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 114.BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
TABLE 115.BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 116.BAXTER INTERNATIONAL INC.: OPERATING SEGMENTS
TABLE 117.BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 118.BAXTER INTERNATIONAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 119.ANGIODYNAMICS INC.: KEY EXECUTIVES
TABLE 120.ANGIODYNAMICS INC.: COMPANY SNAPSHOT
TABLE 121.ANGIODYNAMICS INC.: OPERATING SEGMENTS
TABLE 122.ANGIODYNAMICS INC.: PRODUCT PORTFOLIO
TABLE 123.ANGIODYNAMICS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 124.B.BRAUN MELSUNGEN AG: KEY EXECUTIVES
TABLE 125.B.BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 126.B.BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 127.B.BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 128.B.BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 129.COOK GROUP: KEY EXECUTIVES
TABLE 130.COOK GROUP: COMPANY SNAPSHOT
TABLE 131.COOK GROUP: OPERATING SEGMENTS
TABLE 132.COOK GROUP: PRODUCT PORTFOLIO
TABLE 133.COOK GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 134.FRESENIUS: KEY EXECUTIVES
TABLE 135.FRESENIUS: COMPANY SNAPSHOT
TABLE 136.FRESENIUS: OPERATING SEGMENTS
TABLE 137.FRESENIUS: PRODUCT PORTFOLIO
TABLE 138.FRESENIUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 139.MEDTRONIC, INC.: KEY EXECUTIVES
TABLE 140.MEDTRONIC, INC.: COMPANY SNAPSHOT
TABLE 141.MEDTRONIC, INC.: OPERATING SEGMENTS
TABLE 142.MEDTRONIC, INC.: PRODUCT PORTFOLIO
TABLE 143.MEDTRONIC, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 144.NIKKISO: KEY EXECUTIVES
TABLE 145.NIKKISO: COMPANY SNAPSHOT
TABLE 146.NIKKISO: OPERATING SEGMENTS
TABLE 147.NIKKISO: PRODUCT PORTFOLIO
TABLE 148.NIKKISO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 149.NIPRO CORPORATION: KEY EXECUTIVES
TABLE 150.NIPRO CORPORATION: COMPANY SNAPSHOT
TABLE 151.NIPRO CORPORATION: OPERATING SEGMENTS
TABLE 152.NIPRO CORPORATION: PRODUCT PORTFOLIO
TABLE 153.NIPRO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 154.TORAY MEDICAL: KEY EXECUTIVES
TABLE 155.TORAY MEDICAL: COMPANY SNAPSHOT
TABLE 156.TORAY MEDICAL: OPERATING SEGMENTS
TABLE 157.TORAY MEDICAL: PRODUCT PORTFOLIO
TABLE 158.TORAY MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1.GLOBAL HEMODIALYSIS CATHETERS MARKET SEGMENTATION
FIGURE 2.GLOBAL HEMODIALYSIS CATHETERS MARKET
FIGURE 3.SEGMENTATION HEMODIALYSIS CATHETERS MARKET
FIGURE 4.TOP INVESTMENT POCKET IN HEMODIALYSIS CATHETERS MARKET
FIGURE 5.TOP WINNING STRATEGIES, 2019-2021*
FIGURE 6.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021(%)
FIGURE 7.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
FIGURE 8.MODERATE BARGAINING POWER OF BUYERS
FIGURE 9.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
FIGURE 11.LOW THREAT OF SUBSTITUTION
FIGURE 12.HIGH COMPETITIVE RIVALRY
FIGURE 13.TOP PLAYER POSITIONING, 2020
FIGURE 14.MARKET SHARE ANALYSIS, 2020
FIGURE 15.RESTRAINTS AND DRIVERS: HEMODIALYSIS CATHETERS MARKET
FIGURE 16.HEMODIALYSIS CATHETERS MARKET SEGMENTATION, BY PRODUCT
FIGURE 17.HEMODIALYSIS CATHETERS MARKET FOR CUFFED TUNNELED CATHETER, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 18.HEMODIALYSIS CATHETERS MARKET FOR NON CUFFED TUNNELED CATHETER, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 19.HEMODIALYSIS CATHETERS MARKET FOR NON TUNNELED CATHETER, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 20.HEMODIALYSIS CATHETERS MARKET SEGMENTATION, BY TIP CONFIGURATION
FIGURE 21.HEMODIALYSIS CATHETERS MARKET FOR STEP TIP CATHETER, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 22.HEMODIALYSIS CATHETERS MARKET FOR SPLIT TIP CATHETER, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 23.HEMODIALYSIS CATHETERS MARKET FOR SYMMETRIC CATHETER, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 24.HEMODIALYSIS CATHETERS MARKET SEGMENTATION, BY MATERIAL
FIGURE 25.HEMODIALYSIS CATHETERS MARKET FOR SILICONE, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 26.HEMODIALYSIS CATHETERS MARKET FOR POLYURETHANE, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 27.HEMODIALYSIS CATHETERS MARKET SEGMENTATION, BY END USER
FIGURE 28.HEMODIALYSIS CATHETERS MARKET FOR HOSPITALS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 29.HEMODIALYSIS CATHETERS MARKET FOR HOME DIALYSIS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 30.HEMODIALYSIS CATHETERS MARKET FOR OTHERS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 31.BECTON, DICKINSON AND COMPANY: NET SALES, 2018-2020 ($MILLION)
FIGURE 32.BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 33.BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 34.BAXTER INTERNATIONAL INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 35.BAXTER INTERNATIONAL INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 36.BAXTER INTERNATIONAL INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 37.ANGIODYNAMICS INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 38.ANGIODYNAMICS INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 39.ANGIODYNAMICS INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 40.B.BRAUN MELSUNGEN AG: NET SALES, 2018-2020 ($MILLION)
FIGURE 41.B.BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 42.B.BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 43.COOK GROUP: NET SALES, 2018-2020 ($MILLION)
FIGURE 44.COOK GROUP: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 45.COOK GROUP: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 46.FRESENIUS: NET SALES, 2018-2020 ($MILLION)
FIGURE 47.FRESENIUS: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 48.FRESENIUS: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 49.MEDTRONIC, INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 50.MEDTRONIC, INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 51.MEDTRONIC, INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 52.NIKKISO: NET SALES, 2018-2020 ($MILLION)
FIGURE 53.NIKKISO: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 54.NIKKISO: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 55.NIPRO CORPORATION: NET SALES, 2018-2020 ($MILLION)
FIGURE 56.NIPRO CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 57.NIPRO CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 58.TORAY MEDICAL: NET SALES, 2018-2020 ($MILLION)
FIGURE 59.TORAY MEDICAL: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 60.TORAY MEDICAL: REVENUE SHARE, BY REGION, 2020 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings